{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-236343","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2021-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.315347+00:00","generated_at":"2026-06-29T22:21:48.463736+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Susan Dodson DeVore elected to Anthem board as independent director","bullets":["Elected effective Aug 3, 2021; term expires at 2022 annual meeting; appointed to Audit and Finance Committees.","DeVore recently retired as CEO and Director of Premier, Inc., a healthcare supply chain and technology company.","She brings decades of finance, strategy, and healthcare consulting experience, including as a partner at Ernst & Young.","She also serves on the board of UNUM Group.","Board Chair Elizabeth Tallett says DeVore's leadership in driving innovation will provide valuable insights."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-236343","json":"https://secwatch.observer/filing/0001193125-21-236343.json","markdown":"https://secwatch.observer/filing/0001193125-21-236343.md","text":"https://secwatch.observer/filing/0001193125-21-236343.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000119312521236343/0001193125-21-236343-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000119312521236343/d169797d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T22:21:48.463736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4478172253","claim":"Susan Dodson DeVore was elected as independent director at Elevance Health, Inc..","evidence_excerpt":"On August 3, 2021, the Board of Directors (the “Board”) of the Company elected Susan Dodson DeVore to serve as an independent director effective immediately, with a term expiring at the Company’s 2022 annual meeting of shareholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000119312521236343/0001193125-21-236343-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"independent director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}